FrancophonIA/ELRC3.0 huggingface dataset:
English: Entacapone Orion tablets contain entacapone and are used together with levodopa to treat Parkinson's disease.
Slovenian: Tablete Entacapone Orion vsebujejo entakapon in jih uporabljamo skupaj z levodopo za zdravljenje Parkinsonove bolezni.
English: • if you are taking a medicine which may cause dizziness or light-headedness (low blood pressure) when rising from a chair or bed;
Slovenian: • če jemljete zdravila, zaradi katerih pri vstajanju s stola ali postelje postanete omotični ali se vam stemni pred očmi (se vam zniža krvni tlak);
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, and carcinogenic potential.
Slovenian: Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih odmerkih, genotoksičnosti in kancerogenega potenciala ne kažejo posebnega tveganja za človeka.
English: Entacapone Orion may make it harder for you to digest iron.
Slovenian: Zdravilo Entacapone Orion lahko oteži prebavljanje železa.
English: Entacapone Orion is taken together with medicines containing levodopa (either levodopa/carbidopa preparations or levodopa/benserazide preparations).
Slovenian: Zdravilo Entacapone Orion se jemlje skupaj z zdravili, ki vsebujejo levodopo (bodisi pripravki levodope/karbidope bodisi pripravki levodope/benserazida).
English: • if you experience diarrhoea, monitoring of your weight is recommended in order to avoid potentially excessive weight loss;
Slovenian: • če pride do driske, je priporočljivo spremljanje telesne mase, da ne bi prišlo do prevelike izgube telesne mase;
English: As Entacapone Orion tablets will be taken together with other levodopa medicines, please also read the package leaflets of these medicines carefully.
Slovenian: Ker boste tablete Entacapone Orion jemali skupaj z drugimi zdravili z levodopo, skrbno preberite tudi njihova navodila za uporabo.
English: Skin and subcutaneous tissue disorders Rare:
Slovenian: Bolezni kože in podkožja redki:
English: Brownish-orange, oval, biconvex film-coated tablet with "COMT" engraved on one side.
Slovenian: Rjavkastooranžna, ovalna, bikonveksna filmsko obložena tableta z vtisnjenim napisom “COMT” na eni strani.
English: Elderly No dosage adjustment of entacapone is required for elderly.
Slovenian: Starejši Za starejše ni potrebno prilagajanje odmerjanja entakapona.
English: When stopping your doctor may need to re-adjust the dosage of your other medicines to treat Parkinson´s disease.
Slovenian: Pri prekinitvi jemanja vam bo zdravnik mogoče prilagodil odmerjanje vaših drugih zdravil za Parkinsonovo bolezen.
English: CARTON AND BOTTLE LABEL
Slovenian: ŠKATLA IN NALEPKA NA STEKLENIČKI
English: entacapone orion 200 mg [carton only]
Slovenian: entacapone orion 200 mg [samo na škatli]
English: Entacapone decreases the metabolic loss of levodopa to 3-O-methyldopa (3-OMD) by inhibiting the COMT enzyme.
Slovenian: Entakapon z zaviranjem encima COMT zmanjšuje izgubo levodope zaradi presnavljanja v 3-O-metildopo (3-OMD).
English: What you need to know before you take Entacapone Orion
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Entacapone Orion
English: In addition, Entacapone Orion taken with levodopa may make you feel very drowsy, or cause you to sometimes suddenly fall asleep.
Slovenian: Poleg tega lahko zdravilo Entacapone Orion, ki ga vzamete skupaj z levodopo, povzroči hudo zaspanost ali povzroči, da včasih nenadoma zaspite.
English: The other major class of adverse reactions are gastrointestinal symptoms, including nausea, vomiting, abdominal pain, constipation and diarrhoea.
Slovenian: Druga pomembna skupina neželenih učinkov so simptomi s strani prebavil, ki obsegajo navzejo, bruhanje, bolečine v trebuhu, zapeko in diarejo.
English: Thus, entacapone should be administered cautiously to patients being treated with medicinal products metabolised by catechol-Omethyl transferase (COMT), e.g. rimiterole, isoprenaline, adrenaline, noradrenaline, dopamine, dobutamine, alpha-methyldopa, and apomorphine (see also section 4.5).
Slovenian: Zato je potrebna previdnost pri predpisovanju entakapona bolnikom, zdravljenim z zdravili, ki jih presnavlja katehol-O-metiltransferaza (COMT), npr. z rimiterolom, izoprenalinom, adrenalinom, noradrenalinom, dopaminom, dobutaminom, alfametildopo in apomorfinom (glejte tudi poglavje 4.5).
English: • Excessive movements (hyperkinesias), worsening of symptoms of Parkinson´s disease,
Slovenian: • čezmerni gibi (hiperkinezije), poslabšanje simptomov Parkinsonove bolezni, dolgotrajni mišični krči (distonija);
English: Parkinsonism aggravated, dizziness, dystonia, hyperkinesia
Slovenian: poslabšanje parkinsonizma, omotičnost, distonija, hiperkinezija
English: Entacapone Orion has no effect on relieving the symptoms of Parkinson's disease unless taken with levodopa.
Slovenian: Zdravilo Entacapone Orion ne lajša simptomov Parkinsonove bolezni, če ga bolnik ne vzame skupaj z levodopo.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Slovenian: Druga zdravila in zdravilo Entacapone Orion Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: Entacapone Orion contains soya lecithin.
Slovenian: Zdravilo Entacapone Orion vsebuje sojin lecitin.
English: Entacapone Orion aids levodopa in relieving the symptoms of Parkinson's disease.
Slovenian: Zdravilo Entacapone Orion pomaga levodopi pri lajšanju simptomov Parkinsonove bolezni.
English: Entacapone is administered orally and simultaneously with each levodopa/carbidopa or levodopa/benserazide dose.
Slovenian: Entakapon se uporablja peroralno in sočasno z vsakim odmerkom levodope/karbidope ali levodope/benserazida.
English: Your doctor may advise you to slowly discontinue the treatment with Entacapone Orion and other medicines to treat Parkinson's disease.
Slovenian: Zdravnik vam bo morda svetoval, da zdravilo Entacapone Orion in druga zdravila za Parkinsonovo bolezen prenehate jemati postopoma.
English: See section 4 Possible side effects for the characteristics of NMS;
Slovenian: Za značilnosti NMS glejte poglavje 4 Možni neželeni učinki;
English: Usually side effects caused by Entacapone Orion are mild to moderate.
Slovenian: Neželeni učinki, ki jih povzroča zdravilo Entacapone Orion, so navadno blagi do zmerni.
English: • abdominal pain.
Slovenian: • bolečine v trebuhu.
English: Entacapone in association with levodopa has been associated with isolated cases of excessive daytime somnolence and sudden sleep onset episodes.
Slovenian: Entakapon v povezavi z levodopo povezujejo s posameznimi primeri čezmerne zaspanosti podnevi in napadov nenadnega spanja.
English: Microcrystalline cellulose Croscarmellose sodium Povidone
Slovenian: Jedro tablete mikrokristalna celuloza natrijev karmelozat, premreženi povidon magnezijev stearat
English: Entacapone Orion taken with levodopa may cause drowsiness and may cause you to sometimes suddenly fall asleep.
Slovenian: Zdravilo Entacapone Orion, ki ga vzamete skupaj z levodopo, lahko povzroča zaspanost ali povzroči, da včasih nenadoma zaspite.
English: What Entacapone Orion contains - The active substance is entacapone.
Slovenian: Kaj vsebuje zdravilo Entacapone Orion - Zdravilna učinkovina je entakapon.
English: - The other ingredients in the tablet core are microcrystalline cellulose, croscarmellose sodium,
Slovenian: - Druge sestavine zdravila v jedru tablete so mikrokristalna celuloza, premreženi natrijev karmelozat, povidon in magnezijev stearat.
English: Urine discoloration General disorders and administration site conditions Common:
Slovenian: sprememba barve urina Splošne težave in spremembe na mestu aplikacije pogosti:
English: Do not take Entacapone Orion
Slovenian: Ne jemljite zdravila Entacapone Orion
English: Nervous system disorders Very common:
Slovenian: Bolezni živčevja zelo pogosti:
English: Skin, hair, beard and nail discolourations
Slovenian: sprememba barve kože, las, brade in nohtov
English: Entacapone Orion taken together with levodopa may lower your blood pressure, which may make you feel light-headed or dizzy.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Zdravilo Entacapone Orion, ki ga jemljete skupaj z levodopo, vam lahko zniža krvni tlak, zaradi česar se vam lahko stemni pred očmi ali postanete omotični.
English: In study I, daily ON time (hours) was measured from home diaries and in study II, the proportion of daily ON time.
Slovenian: V študiji I je bilo dnevno obdobje, ko je bil izražen učinek zdravil (obdobje ‘ON'), merjeno v urah na podlagi dnevnikov, ki so jih bolniki vodili doma.
English: • feeling sick (nausea);
Slovenian: • slabost s siljenjem na bruhanje (navzea);
English: Yellow iron oxide (E 172) Red iron oxide (E 172) Titanium dioxide (E 171)
Slovenian: Filmska obloga polivinil alkohol, delno hidroliziran smukec makrogol sojin lecitin rumeni železov oksid (E172) rdeči železov oksid (E172) titanov dioksid (E171)
English: Bottle label
Slovenian: Nalepka na steklenički
English: Entacapone therapy should be administered cautiously to patients with ischaemic heart disease.
Slovenian: Pri bolnikih z ishemično boleznijo srca je treba zdravljenje z entakaponom uporabljati previdno.
English: - Hypersensitivity to the active substance or to peanut or soya or to any of the excipients listed in section 6.1.
Slovenian: - Preobčutljivost za zdravilno učinkovino, arašide ali sojo ali katero koli pomožno snov,
English: apomorphine;
Slovenian: apomorfin;
English: Diarrhoea, abdominal pain, dry mouth, constipation, vomiting
Slovenian: diareja, bolečine v trebuhu, suha usta, zapeka, bruhanje zelo redki:
English: Impulse control disorders: Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments such as Entacapone Orion in association with levodopa (see section 4.4).
Slovenian: Motnje pri obvladovanju impulzov: Pri bolnikih, ki se zdravijo z agonisti dopamina in/ali drugimi dopaminergičnimi zdravili, kot je zdravilo Entacapone Orion v povezavi z levodopo, lahko pride do patološkega hazardiranja, povečanega libida, hiperseksualnosti, kompulzivnega zapravljanja ali nakupovanja, prenajedanja ali kompulzivnega prenajedanja (glejte poglavje 4.4).
English: Hence, patients who are taking standard levodopa/benserazide preparations may need a larger reduction of levodopa dose when entacapone is initiated.
Slovenian: Na začetku zdravljenja z entakaponom je zato včasih treba bolnikom, ki jemljejo standardne pripravke levodope/benserazida, bolj zmanjšati odmerek levodope.
English: What Entacapone Orion looks like and contents of the pack Entacapone Orion 200 mg film-coated tablets are brownish-orange, oval tablets with "COMT" engraved on one side.
Slovenian: Entacapone Orion 200 mg filmsko obložene tablete so rjavkastooranžne, ovalne tablete z vtisnjenim napisom “COMT” na eni strani.
English: Each tablet contains 200 mg of entacapone,
Slovenian: Vsaka tableta vsebuje 200 mg entakapona,
English: Patients and carers should be made aware that behavioural symptoms of impulse control disorders including pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments such as Entacapone Orion in association with levodopa.
Slovenian: Bolnike in njihove skrbnike je treba opozoriti, da pri bolnikih, ki se zdravijo z agonisti dopamina in/ali drugimi dopaminergičnimi zdravili, kot je zdravilo Entacapone Orion v povezavi z levodopo, lahko pride do vedenjskih simptomov, ki so znak motenj pri obvladovanju impulzov, kar vključuje patološko hazardiranje, povečan libido, hiperseksualnost, kompulzivno zapravljanje ali nakupovanje, prenajedanje in kompulzivno prenajedanje.
English: Entacapone Orion 200 mg film-coated tablets
Slovenian: Entacapone Orion 200 mg filmsko obložene tablete
English: • nausea;
Slovenian: • izpuščaji;
English: General characteristics of the active substance
Slovenian: Splošne značilnosti zdravilne učinkovine Absorpcija
English: Hepatic function tests abnormal
Slovenian: nenormalni izvidi testov jetrne funkcije pogostnost neznana:
English: When Entacapone Orion is given at higher doses:
Slovenian: Pri uporabi višjih odmerkov zdravila Entacapone Orion:
English: Each tablet contains 200 mg of entacapone.
Slovenian: Vsaka tableta vsebuje 200 mg entakapona.
English: Entacapone Orion 200 mg film-coated tablets entacapone
Slovenian: Entacapone Orion 200 mg filmsko obložene tablete entakapon
English: How to take Entacapone Orion
Slovenian: Kako jemati zdravilo Entacapone Orion
English: Adverse drug reactions*
Slovenian: Srčne bolezni**
English: Therefore, the use of Entacapone Orion in children or adolescents cannot be recommended.
Slovenian: Izkušenj z uporabo zdravila Entacapone Orion pri bolnikih, ki so stari manj kot 18 let, je malo, zato uporabe zdravila Entacapone Orion pri otrocih in mladostnikih ni mogoče priporočati.
English: Daily ON time (Mean ±SD)
Slovenian: Preglednica 2: Dnevno obdobje ‘ON' (povprečje ± S.D.)
English: Urticaria
Slovenian: kolitis
English: • being sick (vomiting), diarrhoea, abdominal pain, constipation, dry mouth;
Slovenian: • bruhanje, driska, bolečine v trebuhu, zapeka, suha usta;
English: Hepatobiliary disorders Rare:
Slovenian: eritematozen ali makulopapularen izpuščaj zelo redki:
English: Talk to your doctor or pharmacist before taking Entacapone Orion:
Slovenian: Pred začetkom jemanja zdravila Entacapone Orion se posvetujte z zdravnikom ali farmacevtom:
English: How to store Entacapone Orion
Slovenian: Shranjevanje zdravila Entacapone Orion
English: The dose of other medicines to treat Parkinson's disease may need to be adjusted when you start taking Entacapone Orion.
Slovenian: Morda bo ob uvedbi zdravila Entacapone Orion potrebno prilagoditi odmerke drugih zdravil za Parkinsonovo bolezen.
English: - A previous history of neuroleptic malignant syndrome (NMS) and/or non-traumatic rhabdomyolysis.
Slovenian: - Anamneza nevroleptičnega malignega sindroma (NMS - ‘Neuroleptic Malignant Syndrome')
English: • Rashes;
Slovenian: • koprivnica.
English: Neuroleptic Malignant Syndrome (NMS) is a serious but rare reaction to certain medicines, and may occur especially when Entacapone Orion and other medicines to treat Parkinson's disease are suddenly stopped or the dose is suddenly reduced.
Slovenian: Do nje lahko pride zlasti pri nenadni prekinitvi zdravljenja z zdravilom Entacapone Orion in drugimi zdravili za Parkinsonovo bolezen oziroma pri nenadnem znižanju odmerka teh zdravil.
English: Uncommon:
Slovenian: občasni:
English: White high-density polyethylene (HDPE) bottles with white tamper proof polypropylene (PP)
Slovenian: Bele stekleničke iz polietilena visoke gostote (HDPE), z belim polipropilenskim (PP) pokrovčkom, odpornim proti nepooblaščenemu odpiranju, v katerih je po 30, 60, 100 ali 175 tablet.
English: • Uncontrollable movements with difficulty in performing voluntary movements (dyskinesias);
Slovenian: • nehoteni gibi z oteženim izvajanjem hotenih gibov (diskinezije);
English: For patients experiencing diarrhoea, a follow-up of weight is recommended in order to avoid potential excessive weight decrease.
Slovenian: Da ne bi prišlo do čezmerne izgube telesne mase, je pri bolnikih z diarejo priporočljivo spremljanje telesne mase.
English: The maximum recommended dose is 10 tablets per day, i.e. 2,000 mg of Entacapone Orion.
Slovenian: Najvišji priporočeni odmerek je 10 tablet na dan, t.j.
English: It is available as tablets (5 mg).
Slovenian: Na voljo je v obliki tablet (5 mg).
English: The European Commission granted a marketing authorisation valid throughout the European Union for Desloratadine Actavis on 13 January 2012.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Desloratadine Actavis, veljavno po vsej Evropski uniji, odobrila dne 13. januarja 2012.
English: The full EPAR for Desloratadine Actavis can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Desloratadine Actavis je na voljo na spletni strani agencije ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: This means that Desloratadine Actavis is similar to a ‘reference medicine' already authorised in the European Union (EU) called Aerius.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Aerius.
English: For more information about treatment with Desloratadine Actavis, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Desloratadine Actavis preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte s svojim zdravnikom ali farmacevtom.
English: This is a summary of the European public assessment report (EPAR) for Desloratadine Actavis.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Desloratadine Actavis.
English: Because Desloratadine Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Desloratadine Actavis generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so koristi in tveganja enaki kot pri referenčnem zdravilu.
English: Desloratadine Actavis is used to relieve the symptoms of allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) or urticaria (a skin condition caused by an allergy, with symptoms including itching and hives).
Slovenian: Zdravilo Desloratadine Actavis se uporablja za lajšanje simptomov alergijskega rinitisa (vnetja nosne votline, ki ga povzroči alergija, na primer seneni nahod ali alergija na pršice) ali urtikarije (bolezni kože, ki jo povzroča alergija in katere simptomi vključujejo srbenje in izpuščaje).
English: What are the benefits and risks of Desloratadine Actavis?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Desloratadine Actavis?
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Desloratadine Actavis.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil zdravilo Desloratadine Actavis, na podlagi česar je oblikoval mnenje za odobritev dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: Other information about Desloratadine Actavis
Slovenian: Druge informacije o zdravilu Desloratadine Actavis
English: The Committee recommended that Desloratadine Actavis be given marketing authorisation.
Slovenian: Odbor je zato priporočil, da se za zdravilo Desloratadine Actavis odobri dovoljenje za promet.
English: Because Desloratadine Actavis is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Aerius.
Slovenian: Ker je zdravilo Desloratadine Actavis generično zdravilo, so bile študije pri bolnikih omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Aerius.
English: Desloratadine Actavis is a ‘generic medicine'.
Slovenian: Desloratadine Actavis je „generično zdravilo“.
English: The CHMP concluded that, in accordance with EU requirements, Desloratadine Actavis has been shown to have comparable quality and to be bioequivalent to Aerius.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Desloratadine Actavis primerljivo raven kakovosti kot zdravilo Aerius ter da mu je biološko enakovredno.
English: Desloratadine Actavis is a medicine containing the active substance desloratadine.
Slovenian: Desloratadine Actavis je zdravilo, ki vsebuje zdravilno učinkovino desloratadin.
English: The active substance in Desloratadine Actavis, desloratadine, is an antihistamine.
Slovenian: Zdravilna učinkovina zdravila Desloratadine Actavis je desloratadin, ki je antihistaminik.
English: Why has Desloratadine Actavis been approved?
Slovenian: Zakaj je bilo zdravilo Desloratadine Actavis odobreno?
English: It works by blocking the receptors to which histamine, a substance in the body that causes allergic symptoms, normally
Slovenian: Desloratadin deluje kot zaviralec receptorjev, na katere se običajno veže histamin, tj. snov v telesu, ki povzroča
English: How has Desloratadine Actavis been studied?
Slovenian: Kako je bilo zdravilo Desloratadine Actavis raziskano?
English: What is Desloratadine Actavis used for?
Slovenian: Za kaj se zdravilo Desloratadine Actavis uporablja?
English: What is Desloratadine Actavis?
Slovenian: Kaj je zdravilo Desloratadine Actavis?
English: How is Desloratadine Actavis used?
Slovenian: Kako se zdravilo Desloratadine Actavis uporablja?
English: How does Desloratadine Actavis work?
Slovenian: Kako zdravilo Desloratadine Actavis deluje?
English: Hands and equipment should be disinfected after use.
Slovenian: Po uporabi je treba roke in opremo razkužiti.
English: The European Commission granted a marketing authorisation valid throughout the European Union, for Poulvac E. coli on 15 June 2012.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Poulvac E. coli, veljavno po vsej Evropski uniji, izdala 15. junija 2012.
English: The full EPAR for Poulvac E. coli can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila Poulvac E. coli je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: In addition, a positive effect of the vaccine was shown on average daily weight gain, number of antibiotic treatment days and percentage of animals marketed compared to controls.
Slovenian: Poleg tega se je pozitiven učinek cepiva pokazal v povprečnem dnevnem pridobivanju telesne mase, številu dni zdravljenja z antibiotiki in odstotku živali, danih na trg, v primerjavi s kontrolno skupino.
English: The bacterium is alive, but it has been weakened by removal of a gene (aroA) so that it does not cause disease, which makes it suitable for use in a vaccine.
Slovenian: Bakterija je živa, vendar oslabljena z odstranitvijo gena (aroA), tako da ne povzroča bolezni in je zato uporabna kot cepivo.
English: This is a summary of the European Public Assessment Report (EPAR) for Poulvac E. coli.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Poulvac E. coli.
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Poulvac E. coli's benefits are greated that its risks and recommended that it be approved in the EU.
Slovenian: Odbor za zdravila za uporabo v veterinarski medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Poulvac E. coli večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
English: It contains the live bacteria Escherichia coli, type O78, strain EC34195 with a gene (aroA) deleted.
Slovenian: Vsebuje živo bakterijo Escherichia coli, vrsta O78, sev EC34195 z delecijo gena aroA.
English: Animals undergoing antibacterial or immunosuppressive treatment (treatment that reduces the activity of the immune system) should not be vaccinated.
Slovenian: Živali, ki prejemajo antibiotike ali imunosupresivna zdravila (ki zmanjšujejo delovanje imunskega sistema), ne smejo biti cepljene.
English: The vaccine should not be used within six weeks before the start of the laying period or in birds in lay (currently producing eggs).
Slovenian: Cepivo se ne sme uporabljati v šestih tednih pred začetkom obdobja nesnosti ali pri pticah v obdobju nesnosti (ki trenutno proizvajajo jajca).